NCT07273890

Brief Summary

This study will employ a prospective, multicenter, controlled design. It will be conducted across multiple centers, with participated centers randomly assigned to one of four groups: Group A, Group B, Group C, and Group D. The research will primarily focus on the AI-based analysis of colonoscopic images to calculate the following metrics: caecal intubation time, red-out percentage, and the AI-based red-out avoiding score. Based on the study's implementation protocol, a decision will be made regarding whether to provide real-time feedback. Additionally, the presence of any complications will be assessed both during and after the colonoscopy procedure.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
576

participants targeted

Target at P75+ for not_applicable

Timeline
24mo left

Started Dec 2025

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Dec 2025Apr 2028

First Submitted

Initial submission to the registry

November 27, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 10, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

December 10, 2025

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2027

Expected
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2028

Last Updated

December 10, 2025

Status Verified

October 1, 2025

Enrollment Period

1.7 years

First QC Date

November 27, 2025

Last Update Submit

November 27, 2025

Conditions

Keywords

ColonoscopyIntubationReal-time feedbackRed-out

Outcome Measures

Primary Outcomes (3)

  • Red-out percentage

    The impact of real-time feedback on red-out percentage.

    Stage 3 (projected to begin in 3-6 months)

  • Caecal intubation time

    The impact of real-time feedback on caecal intubation time.

    Stage 3 (projected to begin in 3-6 months)

  • AI-based red-out avoiding score

    The impact of real-time feedback on AI-based red-out avoiding score.

    Stage 3 (projected to begin in 3-6 months)

Secondary Outcomes (1)

  • Complications

    Stage 3 (projected to begin in 3-6 months)

Study Arms (4)

Group A

SHAM COMPARATOR

During colonoscopy intubation, AI system is used to calculate and analyze "caecal intubation time," "red-out percentage," and the "AI-based red-out avoiding score" in real-time; however, these results are not provided as feedback to the operating colonoscopist.

Other: AI system

Group B

EXPERIMENTAL

During colonoscopy intubation, AI system is used to calculate and analyze "caecal intubation time," "red-out percentage," and the "AI-based red-out avoiding score" in real-time, with only the caecal intubation time being provided as feedback to the operator, while the red-out percentage and AI-based red-out avoiding score are withheld.

Other: AI system

Group C

EXPERIMENTAL

During colonoscopy intubation, AI system is used to calculate and analyze "caecal intubation time," "red-out percentage," and the "AI-based red-out avoiding score" in real-time, with only the red-out percentage being provided as feedback to the operator, while the caecal intubation time and AI-based red-out avoiding score are withheld.

Other: AI system

Group D

EXPERIMENTAL

During colonoscopy intubation, AI system is used to calculate and analyze the "caecal intubation time" "red-out percentage," and "AI-based red-out avoiding score" in real-time, with all three results provided as feedback to the operating colonoscopist.

Other: AI system

Interventions

AI-system Performance Feedback in group B, group C, and group D.

Group AGroup BGroup CGroup D

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Study Participants (Patients):
  • Aged 18 to 70 years, any gender. Individuals scheduled to undergo diagnostic or screening colonoscopy at the investigational site.
  • Colonoscopists:
  • Expert-level colonoscopists (having performed a total of \>1000 colonoscopy procedures).
  • Right-handed.

You may not qualify if:

  • Study Participants (Patients):
  • Individuals undergoing the following procedures:
  • cases with a history of colorectal surgery; cases with a history of chemotherapy, raditherapy; cases with a history of abdominal, and/or pelvic surgery; cases with a history of difficult colonoscopies; cases with colorectal tumours and obstructive lesions; cases with colorectal diverticula; cases with ulcerative colitis or Crohn's disease; cases with ischemic bowel disease; cases with colorectal polyposis; cases with melanosis coli; cases undergoing sigmoidoscopy; cases with poor intestional cleanliness (segment Boston bowel preparation scale (BBPS) of \< 2 points, total BBPS of \< 6 points); cases undergoing therapy procedures such as biopsy or CSP during the intubation phase; cases with transparent cap assisted colonoscopy; cases with water-assisted colonoscopy; cases with air insufflation level of M or L; cases failed caecal intubation within 15 min; cases with colonoscope stiffness level \> 0; obese cases or underweight cases; and cases refusing participation.
  • Individuals who decline to provide informed consent.
  • Colonoscopists:
  • Those who have performed fewer than 300 complete colonoscopies in any calendar year within the past three years.
  • Those who decline to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Intelligent Systems

Intervention Hierarchy (Ancestors)

Artificial IntelligenceAlgorithmsMathematical Concepts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2025

First Posted

December 10, 2025

Study Start

December 10, 2025

Primary Completion (Estimated)

August 31, 2027

Study Completion (Estimated)

April 20, 2028

Last Updated

December 10, 2025

Record last verified: 2025-10